For 2022, 29 European Union/European Economic Area (EU/EEA) countries reported 8 565 confirmed cases of Shiga toxin-producing Escherichia coli (STEC) infection.
Meningococcal disease is caused by Neisseria meningitidis, a bacterium with human carriers as the only reservoir. It is carried in the nose, where it can remain for long periods without producing symptoms.
Haemophilus influenzae type b (Hib) is an obligate human pathogen and an important cause of invasive bacterial infections in both children and adults, with the highest incidence among young children.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6 - 12 August 2023 and includes updates on measles, COVID-19, swine flu, mpox, diphtheria, West Nile virus, avian influenza, dengue, Crimean-Congo haemorrhagic fever, and invasive meningococcal disease.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 July 2023 and includes updates on cholera, MERS-CoV, Chikungunya, dengue, COVID-19, West Nile virus, avian influenza, echovirus, botulism, and bacterial meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
This report is based on data for 2018-2020 retrieved on 13 February 2023 from The European Surveillance System (TESSy) and ECDC’s decentralised data storage for antimicrobial resistance and healthcare-associated infections (ARHAI). TESSy is a system for the collection, analysis and dissemination of data on communicable diseases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.